MedPath

Evaluation of eCPR Survivors

Not yet recruiting
Conditions
Extracorporeal Membrane Oxygenation Complication
Cardiac Arrest
Cardiopulmonary Resuscitation
Cardiogenic Shock
Myocardial Infarction
Registration Number
NCT05339854
Lead Sponsor
Charite University, Berlin, Germany
Brief Summary

A cardiac arrest event has severe impact on the patient´s health-related quality of life. Survival of cardiac arrest does not innately translate to favorable quality of life. In particular, highly invasive resuscitation strategies, including extracorporeal cardio-pulmonary resuscitation (ECPR) due to therapy-refractory cardiac arrest, may have impact on long-term outcomes. Therefore, apart from acute medical treatment and physical rehabilitation, long-term effects on cardio-pulmonary, physical and neuro-psychiatric functions after cardiac arrest survival have to be evaluated and optimized. We plan to investigate a bundle of cardio-pulmonary, physical and neuro-psychiatric functions in patients who survived a therapy-refratory cardiac arrest with ECPR.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Adult patients
  • Survival of cardiac arrest
  • Use of extracorporeal cardiopulmonary resuscitation (ECPR) with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) or ECMELLA (VA-ECMO and left-ventricular Impella micro-axial pump)
Exclusion Criteria
  • Non-adult patients
  • No cardiac arrest
  • No use of ECPR
  • Inability to comply with follow-up

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Left ventricular ejection fraction (LVEF)LVEF witihin one year after index cardiac arrest event.

LVEF measured with transthoracic echocardiography.

Secondary Outcome Measures
NameTimeMethod
Vital function: Blood pressureBlood pressure witihin one year after index cardiac arrest event.

Non-invasive blood pressure measurement at rest (unit: mmHg).

Vital function: Peripheral oxygen saturationPeripheral oxygen saturation witihin one year after index cardiac arrest event.

Peripheral oxygen saturation measurement at rest by using pulsoximetry (unit: percent).

Vital function: Electrocardiogram (ECG)ECG activity witihin one year after index cardiac arrest event.

12-lead ECG measurement at rest.

Cognitive functionCognitive function witihin one year after index cardiac arrest event.

Cognitive function measured with a standardized questionnaire and following established scores:

1. Mini-mental-status-test \[0-30 points; higher score means better outcome\],

2. Cerebral Performance Categories Scale \[1-5; lower score means better outcome\].

Sign and symptoms of heart failureSign and symptoms of heart failure witihin one year after index cardiac arrest event.

Sign and symptoms of heart failure measured with a standardized questionnaire and following established score: European Quality of Life 5 Dimensions 3 Level Version \[0-100 points; higher score means better outcome\].

Activity of daily living (ADL)ADL witihin one year after index cardiac arrest event.

ADL measured with a standardized questionnaire and following estbalished score:

Barthel index \[0-100 points; higher score means better outcome\].

Comorbidity levelComorbidity level witihin one year after index cardiac arrest event.

Comorbidity level measured with following established score: Charlson comorbidity index \[0-24 points; lower score means better outcome\].

Number of cardiovascular medicationsNumber of cardiovascular medication witihin one year after index cardiac arrest event.

Number of cardiovascular medications documented with a standardized questionnaire.

Cardiac stress test: ErgometryPhysical function witihin one year after index cardiac arrest event.

Quantitative test to evaluate cardiopulmonary exercise tolerance and physical capacity by using a bicycle.

Cardiac stress test: Walking distancePhysical function witihin one year after index cardiac arrest event.

Quantitative test to evaluate endurance and aerobic capacity by walking for six minutes (six minute walk test).

Trial Locations

Locations (1)

Charité - Universitätsmedizin Berlin

🇩🇪

Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath